Mental Wellness in Moncton

Moncton, New Brunswick is experiencing an acute and severe overdose crisis in June 2026. Between May 29 and June 11, 2026, paramedics responded to 248 suspected overdose calls in the Greater Moncton area (Moncton, Riverview, and Dieppe). Harvest House Atlantic reported 309 overdoses responded to between June 1 and June 11 alone. A suspected contaminant — medetomidine, a potent veterinary tranquilizer — has been detected in the local a powerful synthetic opioid supply, causing heavy sedation that does not always reverse with overdose reversal medication. Frontline harm reduction workers at Ensemble described single days as the worst they had seen since their supervised consumption site opened. Friends were walking city streets carrying overdose reversal medication (Narcan) kits due to the scale of the emergency.

Canada recorded approximately 7,560 apparent opioid toxicity deaths in 2023, according to the Public Health Agency of Canada. While some provinces saw modest declines in 2024, the drug supply crisis has intensified in Atlantic Canada, with veterinary tranquilizers like medetomidine emerging as a new and particularly dangerous adulterant that complicates standard overdose reversal medication-based emergency response. Moncton's June 2026 crisis — with over 300 overdoses in under two weeks — reflects a national pattern of acute, contamination-driven spikes layered on top of a chronic community health crisis.

01. What is happening in Moncton

02. A crisis that did not start this month

New Brunswick recorded 72 opioid deaths in 2023 — a record high at that time, with a powerful synthetic opioid involved in the majority of cases. In 2024, the province saw a 20.4% decrease to 78 drug toxicity deaths, though this remained elevated historically. Ambulance workers administered overdose reversal medication to 689 people suspected of drug overdose in 2023, and to approximately 320 in the first two quarters of 2024 (averaging 53 per month). The province's drug supply has been increasingly contaminated with both a powerful synthetic opioid and novel adulterants including veterinary tranquilizers, creating unpredictable overdose patterns that challenge standard overdose reversal medication response protocols.

03. Why is it getting worse?

The Moncton overdose crisis is driven by several compounding factors: (1) Contamination of the illicit a powerful synthetic opioid supply with medetomidine, a veterinary tranquilizer that causes deep sedation not fully reversible by overdose reversal medication alone; (2) rising homelessness and housing instability in New Brunswick, with street-involved populations at highest risk; (3) limited safe supply and supervised consumption infrastructure relative to demand; (4) a volatile, unpredictable unregulated drug market where potency and adulterants shift rapidly; (5) systemic gaps in Mental Health Support capacity, with the province only recently (April 2026) launching an Addictions and Mental Health Court Program in Moncton to divert justice-involved individuals toward treatment.

04. Where hope still lives

Communities across New Brunswick are responding with overdose reversal medication distribution, harm reduction programs, and peer support networks.

05. In the news

• Dozens in Moncton suffer overdoses, possibly from tranquillizer-laced a powerful synthetic opioidCBC News · 2026-06
• More than 300 drug overdoses reported in Moncton, N.B., in less than two weeksCTV News Atlantic · 2026-06
• 'We've never seen a spike like this': Veterinary tranquillizer suspected in Moncton overdose surgeCBC News · 2026-06
• Spike in Moncton overdose calls raises concerns drug supply may have tranquillizersGlobal News · 2026-06
• A powerful synthetic opioid-related opioid deaths rise in New Brunswick in 2023Global News · 2024
• A sister's search: What it's like to have a loved one on the street battling addictionCBC News · 2025